je.st
news
FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug
2014-06-08 05:12:05| Biotech - Topix.net
The FDA has removed its clinical hold on patient enrollment and dosing of PEGPH20 in an ongoing phase II trial evaluating the investigational compound in patients with pancreatic cancer, permitting the study to resume under a revised protocol.
Tags: study
hold
drug
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||